| Disease Information | ||||||
|---|---|---|---|---|---|---|
| Disease Name | Gene Name | Type | UMLS | Association Type | Score | Source |
| Plasmablastic Lymphoma | MYC | disease | C3472614 | AlteredExpression | 0.1 | disgenet |
| Plasmablastic Lymphoma | MYC | disease | C3472614 | Biomarker | 0.1 | disgenet |
| Plasmablastic Lymphoma | MYC | disease | C3472614 | GeneticVariation | 0.1 | disgenet |
| Plasmablastic Lymphoma | IGH | disease | C3472614 | GeneticVariation | 0.06 | disgenet |
| Plasmablastic Lymphoma | IGH | disease | C3472614 | Biomarker | 0.06 | disgenet |
| Plasmablastic Lymphoma | CD38 | disease | C3472614 | Biomarker | 0.03 | disgenet |
| Plasmablastic Lymphoma | MS4A1 | disease | C3472614 | AlteredExpression | 0.03 | disgenet |
| Plasmablastic Lymphoma | MS4A1 | disease | C3472614 | Biomarker | 0.03 | disgenet |
| Plasmablastic Lymphoma | KRT20 | disease | C3472614 | Biomarker | 0.03 | disgenet |
| Plasmablastic Lymphoma | SDC1 | disease | C3472614 | AlteredExpression | 0.03 | disgenet |
| Plasmablastic Lymphoma | SDC1 | disease | C3472614 | Biomarker | 0.03 | disgenet |
| Plasmablastic Lymphoma | KRT20 | disease | C3472614 | AlteredExpression | 0.03 | disgenet |
| Plasmablastic Lymphoma | CD38 | disease | C3472614 | AlteredExpression | 0.03 | disgenet |
| Plasmablastic Lymphoma | MME | disease | C3472614 | AlteredExpression | 0.02 | disgenet |
| Plasmablastic Lymphoma | MME | disease | C3472614 | Biomarker | 0.02 | disgenet |
| Plasmablastic Lymphoma | PRDM1 | disease | C3472614 | Biomarker | 0.02 | disgenet |
| Plasmablastic Lymphoma | PRDM1 | disease | C3472614 | GeneticVariation | 0.02 | disgenet |
| Plasmablastic Lymphoma | SMUG1 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | PWWP3A | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | FOXP3 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | EBF3 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | HSPB1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | NCAM1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | RTEL1 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | ABCB1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | CTNNB1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | MTOR | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | IL4 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | IL17C | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | BCL2 | disease | C3472614 | GeneticVariation | 0.01 | disgenet |
| Plasmablastic Lymphoma | NOTCH1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | CDKN2A | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | PRDX1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | HSPB2 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | VDR | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | BCL6 | disease | C3472614 | GeneticVariation | 0.01 | disgenet |
| Plasmablastic Lymphoma | ASS1 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | IL6 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | SMAD3 | disease | C3472614 | PosttranslationalModification | 0.01 | disgenet |
| Plasmablastic Lymphoma | PTPRC | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | CD320 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | TNFRSF8 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | IL10 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | HSPB3 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | PAX5 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | IL2 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | ZC3H12D | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | TRBV20OR9-2 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | IL13 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | CD274 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | IRF4 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | ALK | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | KIT | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | RAG2 | disease | C3472614 | Biomarker | 0.01 | disgenet |
| Plasmablastic Lymphoma | H3P10 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| Plasmablastic Lymphoma | TBC1D9 | disease | C3472614 | AlteredExpression | 0.01 | disgenet |
| click here to return to the previous page | ||||||